ADZYNMA

Serial Number 97587783
Registration 7358135
700

Registration Progress

Application Filed
Sep 12, 2022
Under Examination
Approved for Publication
Jan 30, 2024
Published for Opposition
Jan 30, 2024
Registered
Apr 16, 2024

Trademark Image

ADZYNMA

Basic Information

Serial Number
97587783
Registration Number
7358135
Filing Date
September 12, 2022
Registration Date
April 16, 2024
Published for Opposition
January 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 16, 2024
Registration
Registered
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

99
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Original Registrant
99
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
1728 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-16)
Due Date
April 16, 2030
Grace Period Ends
October 16, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Apr 16, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 22, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 22, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 22, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 22, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 22, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 14, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Dec 13, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Dec 13, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Dec 13, 2023 IUAF S USE AMENDMENT FILED Loading...
Dec 12, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jul 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 24, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 24, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, enzyme replacement therapy for thrombotic disorders
First Use Anywhere: Nov 28, 2023
First Use in Commerce: Nov 28, 2023

Classification

International Classes
005